Safety and feasibility of third-party multipotent adult progenitor cells for immunomodulation therapy after liver transplantation--a phase I study (MISOT-I)

BACKGROUND: Liver transplantation is the definitive treatment for many end-stage liver diseases. However, the life-long immunosuppression needed to prevent graft rejection causes clinically significant side effects. Cellular immunomodulatory therapies may allow the dose of immunosuppressive drugs to...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Popp, Felix C, Fillenberg, Barbara, Eggenhofer, Elke, Renner, Philipp, Dillmann, Johannes, Benseler, Volker, Schnitzbauer, Andreas A, Hutchinson, James, Deans, Robert, Ladenheim, Deborah, Graveen, Cheryl A, Zeman, Florian, Koller, Michael, Hoogduijn, Martin J, Geissler, Edward K, Schlitt, Hans J, Dahlke, Marc H
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2011
Fag:
Protocol
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3166276/
https://ncbi.nlm.nih.gov/pubmed/21798013
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-9-124
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker